All Stories

  1. HGF/c-MET: A Potential Target for the Treatment of Various Cancers

    Article • Current Enzyme Inhibition, August 2023, Bentham Science Publishers

    Dr Dinesh Kumar Chellappan, Dr Gaurav Gupta, SHVETANK BHATT

  2. Nanocarriers and their Role in the Treatment of Breast Cancer

    Article • March 2023, Bentham Science Publishers

    SHVETANK BHATT

  3. Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma

    Article • Current Cancer Therapy Reviews, June 2021, Bentham Science Publishers

    SHVETANK BHATT, Rakesh Singh, Dr. JAYARAMAN RAJANGAM

  4. Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression

    Article • Current Drug Targets, February 2021, Bentham Science Publishers

    Neeraj Mishra, SHVETANK BHATT

  5. Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats

    Article • Journal of Basic and Clinical Physiology and Pharmacology, January 2017, De Gruyter

    SHVETANK BHATT

  6. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice

    Article • Journal of Basic and Clinical Physiology and Pharmacology, January 2017, De Gruyter

    SHVETANK BHATT

  7. Neuropharmacological evaluation of a novel 5-HT 3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice

    Article • Indian Journal of Pharmacology, January 2014, Medknow

    SHVETANK BHATT